Skip to main content
. 2017 Jun 27;12(6):e0180067. doi: 10.1371/journal.pone.0180067

Table 2. Demographic characteristics of final sample (N = 112).

Characteristic Randomization Group P-Value
Immediate (N = 55) Delayed (N = 57)
Age, mean (SD) 55.2 (12.3) 50.1 (13.0) 0.038
Male Gender, N (%) 22 (40%) 22 (36%) >0.99
Self-Report White Race, N (%) 53 (96%) 56 (98%) 0.62
Current Smoker, N (%) 7 (13%) 8 (12%) >0.99
Servings of Alcohol Per Week, mean (SD) 3.3 (5.0) 4.9 (7.8) 0.19
Current Treatment for Depression, N (%)
No Treatment 14 (25%) 17 (30%) 0.68
Self-management 1 (2%) 1 (2%) >0.99
Non-pharmacologic Therapy 14 (26%) 11(19%) 0.50
One or more medications 35 (64%) 35 (61%) 0.85
Selective Serotonin Reuptake Inhibitors 19 (35%) 22 (39%) 0.70
Selective Norepinephrine Reuptake Inhibitors 8 (15%) 8 (14%) >0.99
Tricyclic 2 (4%) 1 (2%) 0.61
Bupropion 7 (13%) 9 (16%) 0.80
Monoamine Oxidase Inhibitors 0 0 -
Antipsychotic 0 2 (4%) 0.50
Baseline Patient Health Questionnaire-9 Depression Score, mean (SD) 10.7 (3.7) 10.6 (3.8) 0.84
Baseline Generalized Anxiety Disorder-7 Anxiety Score, mean (SD) 8.6 (5.1) 8.7 (5.4) 0.92
Modified Morisky Score, mean (SD) 2.9 (0.9) 2.9 (1.0) 0.91

N = number; SD = standard deviation.

P-values calculated by Chi-square for categorical values and two-sample t-test or Wilcoxon Rank Sum for continuous values.